182 related articles for article (PubMed ID: 35749589)
1. The Interaction of SWI/SNF with the Ribosome Regulates Translation and Confers Sensitivity to Translation Pathway Inhibitors in Cancers with Complex Perturbations.
Ulicna L; Kimmey SC; Weber CM; Allard GM; Wang A; Bui NQ; Bendall SC; Crabtree GR; Bean GR; Van Rechem C
Cancer Res; 2022 Aug; 82(16):2829-2837. PubMed ID: 35749589
[TBL] [Abstract][Full Text] [Related]
2. Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities.
St Pierre R; Kadoch C
Curr Opin Genet Dev; 2017 Feb; 42():56-67. PubMed ID: 28391084
[TBL] [Abstract][Full Text] [Related]
3. Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers.
Chabanon RM; Morel D; Postel-Vinay S
Semin Cancer Biol; 2020 Apr; 61():180-198. PubMed ID: 31568814
[TBL] [Abstract][Full Text] [Related]
4. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.
Kadoch C; Hargreaves DC; Hodges C; Elias L; Ho L; Ranish J; Crabtree GR
Nat Genet; 2013 Jun; 45(6):592-601. PubMed ID: 23644491
[TBL] [Abstract][Full Text] [Related]
5. BAFfling pathologies: Alterations of BAF complexes in cancer.
Arnaud O; Le Loarer F; Tirode F
Cancer Lett; 2018 Apr; 419():266-279. PubMed ID: 29374542
[TBL] [Abstract][Full Text] [Related]
6. Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies.
Centore RC; Sandoval GJ; Soares LMM; Kadoch C; Chan HM
Trends Genet; 2020 Dec; 36(12):936-950. PubMed ID: 32873422
[TBL] [Abstract][Full Text] [Related]
7. Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities.
Orlando KA; Nguyen V; Raab JR; Walhart T; Weissman BE
Expert Rev Anticancer Ther; 2019 May; 19(5):375-391. PubMed ID: 30986130
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Functional Interplay between the BRD7 and BRD9 Homologues in mSWI/SNF Complexes.
Agbo L; Loehr J; Kougnassoukou Tchara PE; Lambert JP
J Proteome Res; 2023 Jan; 22(1):78-90. PubMed ID: 36484504
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional properties of mSWI/SNF chromatin remodeling complexes revealed through single-cell perturbation screens.
Otto JE; Ursu O; Wu AP; Winter EB; Cuoco MS; Ma S; Qian K; Michel BC; Buenrostro JD; Berger B; Regev A; Kadoch C
Mol Cell; 2023 Apr; 83(8):1350-1367.e7. PubMed ID: 37028419
[TBL] [Abstract][Full Text] [Related]
10. Biallelic germline and somatic mutations in malignant mesothelioma: multiple mutations in transcription regulators including mSWI/SNF genes.
Yoshikawa Y; Sato A; Tsujimura T; Otsuki T; Fukuoka K; Hasegawa S; Nakano T; Hashimoto-Tamaoki T
Int J Cancer; 2015 Feb; 136(3):560-71. PubMed ID: 24916674
[TBL] [Abstract][Full Text] [Related]
11. The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting.
Pan J; McKenzie ZM; D'Avino AR; Mashtalir N; Lareau CA; St Pierre R; Wang L; Shilatifard A; Kadoch C
Nat Genet; 2019 Apr; 51(4):618-626. PubMed ID: 30858614
[TBL] [Abstract][Full Text] [Related]
12. Advances in the role of SWI/SNF complexes in tumours.
Li Z; Zhao J; Tang Y
J Cell Mol Med; 2023 Apr; 27(8):1023-1031. PubMed ID: 36883311
[TBL] [Abstract][Full Text] [Related]
13. SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2.
Kim KH; Kim W; Howard TP; Vazquez F; Tsherniak A; Wu JN; Wang W; Haswell JR; Walensky LD; Hahn WC; Orkin SH; Roberts CW
Nat Med; 2015 Dec; 21(12):1491-6. PubMed ID: 26552009
[TBL] [Abstract][Full Text] [Related]
14. The spectrum of SWI/SNF mutations, ubiquitous in human cancers.
Shain AH; Pollack JR
PLoS One; 2013; 8(1):e55119. PubMed ID: 23355908
[TBL] [Abstract][Full Text] [Related]
15. The genetic alteration spectrum of the SWI/SNF complex: The oncogenic roles of BRD9 and ACTL6A.
Sima X; He J; Peng J; Xu Y; Zhang F; Deng L
PLoS One; 2019; 14(9):e0222305. PubMed ID: 31504061
[TBL] [Abstract][Full Text] [Related]
16. Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors.
Abou Alaiwi S; Nassar AH; Xie W; Bakouny Z; Berchuck JE; Braun DA; Baca SC; Nuzzo PV; Flippot R; Mouhieddine TH; Spurr LF; Li YY; Li T; Flaifel A; Steinharter JA; Margolis CA; Vokes NI; Du H; Shukla SA; Cherniack AD; Sonpavde G; Haddad RI; Awad MM; Giannakis M; Hodi FS; Liu XS; Signoretti S; Kadoch C; Freedman ML; Kwiatkowski DJ; Van Allen EM; Choueiri TK
Cancer Immunol Res; 2020 Aug; 8(8):1075-1084. PubMed ID: 32321774
[TBL] [Abstract][Full Text] [Related]
17. Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes.
Mashtalir N; D'Avino AR; Michel BC; Luo J; Pan J; Otto JE; Zullow HJ; McKenzie ZM; Kubiak RL; St Pierre R; Valencia AM; Poynter SJ; Cassel SH; Ranish JA; Kadoch C
Cell; 2018 Nov; 175(5):1272-1288.e20. PubMed ID: 30343899
[TBL] [Abstract][Full Text] [Related]
18. FUS oncofusion protein condensates recruit mSWI/SNF chromatin remodeler via heterotypic interactions between prion-like domains.
Davis RB; Kaur T; Moosa MM; Banerjee PR
Protein Sci; 2021 Jul; 30(7):1454-1466. PubMed ID: 34018649
[TBL] [Abstract][Full Text] [Related]
19. Chromatin landscape signals differentially dictate the activities of mSWI/SNF family complexes.
Mashtalir N; Dao HT; Sankar A; Liu H; Corin AJ; Bagert JD; Ge EJ; D'Avino AR; Filipovski M; Michel BC; Dann GP; Muir TW; Kadoch C
Science; 2021 Jul; 373(6552):306-315. PubMed ID: 34437148
[TBL] [Abstract][Full Text] [Related]
20. Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion.
Battistello E; Hixon KA; Comstock DE; Collings CK; Chen X; Rodriguez Hernaez J; Lee S; Cervantes KS; Hinkley MM; Ntatsoulis K; Cesarano A; Hockemeyer K; Haining WN; Witkowski MT; Qi J; Tsirigos A; Perna F; Aifantis I; Kadoch C
Mol Cell; 2023 Apr; 83(8):1216-1236.e12. PubMed ID: 36944333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]